Showing 1,221 - 1,240 results of 2,245 for search '"Рациональная фармакотерапия в кардиологии"', query time: 0.07s Refine Results
  1. 1221
    ANTIAGGREGANT THERAPY OVERCOMES LIMITS

    ANTIAGGREGANT THERAPY OVERCOMES LIMITS by I. Andreeva

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 1222
    Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl)

    Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) by V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina

    Published 2023-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 1223
    Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State

    Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall... by I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova

    Published 2019-07-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 1224
    Index of the Papers Published in 2022

    Index of the Papers Published in 2022 by Article Editorial

    Published 2023-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 1225
    ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES

    ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES by E. N. Dankovtseva

    Published 2015-09-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 1226
    ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS

    ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS by T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 1227
    OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS

    OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS by S. F. Zadvorev, A. A. Yakovlev, A. S. Pushkin, S. A. Rukavishnikova, A. E. Filippov, A. G. Obrezan

    Published 2018-07-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 1228
    CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS

    CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS by S. Y. Martsevich

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 1229
    Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age

    Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age by N. I. Solomakhina, A. S. Lishuta, A. V. Dementieva

    Published 2022-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 1230
    EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY

    EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY by E. V. Goncharova, A. V. Govorin

    Published 2015-09-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 1231
    PRIORITIES IN CONCEPT OF CARDIOVASCULAR RISK FACTORS IN IRRADIATED PATIENTS AT DISTANT PERIOD AFTER CHERNOBYL NUCLEAR DISASTER BASED ON PROSPECTIVE COHORT DATA

    PRIORITIES IN CONCEPT OF CARDIOVASCULAR RISK FACTORS IN IRRADIATED PATIENTS AT DISTANT PERIOD AFTER CHERNOBYL NUCLEAR DISASTER BASED ON PROSPECTIVE COHORT DATA by R. G. Oganov, V. S. Sherashov, N. V. Sherashova, M. V. Sherashova, S. K. Kukushkin, O. G. Rudakova, E. A. Zhavoronkova

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 1232
    EDITORIAL

    EDITORIAL by R. G. Oganov

    Published 2015-12-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 1233
    DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II

    DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II by Y. A. Vasyuk, A. V. Lebedev

    Published 2015-12-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 1234
    CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION

    CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION by V. E. Oleynikov, V. A. Budanova, A. V. Kulucin

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 1235
    Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders

    Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders by S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina

    Published 2022-09-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 1236
    REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT

    REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT by A. N. Britov, M. M. Bystrova

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 1237
    On the 90th Anniversary of David M. Aronov

    On the 90th Anniversary of David M. Aronov by article Editorial

    Published 2022-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 1238
    News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing

    News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing by S. Yu. Martsevich, N. P. Kutishenko

    Published 2016-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 1239
    On the 85th Anniversary of Nikolay A. Mazur

    On the 85th Anniversary of Nikolay A. Mazur by article Editorial

    Published 2021-05-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 1240
    SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION

    SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION by D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: